Trial Profile
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Ferric pyrophosphate (Primary)
- Indications Iron deficiency anaemia
- Focus Pharmacokinetics
- Sponsors Rockwell Medical Technologies
- 06 Mar 2017 According to a Rockwell media release, the company will present data from this study at Annual Dialysis Conference Meeting.
- 25 Dec 2015 New trial record